Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AlphaMedix (ORM-2110)
i
Other names:
ORM-2110, 212 lead-labeled peptide, 212Pb AR RMX, 212-Pb-Targeted-Alpha-Emmitter-Therapy, 212Pb-AR-RMX, 212Pb-alphamedix, 212Pb-somatostatin analogue, Lead-212 radiotherapy, ORM 2110, ORM2110, 212Pb-labeled peptide, Pb212-octreotide analog, ²¹²Pb-DOTAMTATE, Pb-212 radiotherapy, SAR447873
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Orano, RadioMedix, Sanofi
Drug class:
Alpha radiation emitter, SSTR2 modulator
Related drugs:
‹
Ac-225 ErbB3 targeted radiotherapy (4)
lintuzumab-Ac225 (4)
RYZ101 (2)
radium Ra-223 dichloride (2)
225Ac-FL-020 (1)
BAY2701439 (1)
I-131-apamistamab (1)
Undisclosed EGFRvIII-targeted alpha therapy (1)
211At-OKT10-B10 (0)
212Pb-DOTAM-GRPR1 (0)
AAA817 (0)
AB001 (0)
CONV01-α (0)
FPI-1434 (0)
FPI-1966 (0)
FPI-2265 (0)
JNJ-6420 (0)
VMT-01 (0)
VMT-𝛼-NET (0)
[²¹¹At]PTT (0)
BAY1862864 (0)
BAY 2315497 (0)
BAY 2287411 (0)
lutetium Lu 177 dotatate (2)
177Lu-LNC1010 (0)
EBTATE (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
Re (0)
Ac-225 ErbB3 targeted radiotherapy (4)
lintuzumab-Ac225 (4)
RYZ101 (2)
radium Ra-223 dichloride (2)
225Ac-FL-020 (1)
BAY2701439 (1)
I-131-apamistamab (1)
Undisclosed EGFRvIII-targeted alpha therapy (1)
211At-OKT10-B10 (0)
212Pb-DOTAM-GRPR1 (0)
AAA817 (0)
AB001 (0)
CONV01-α (0)
FPI-1434 (0)
FPI-1966 (0)
FPI-2265 (0)
JNJ-6420 (0)
VMT-01 (0)
VMT-𝛼-NET (0)
[²¹¹At]PTT (0)
BAY1862864 (0)
BAY 2315497 (0)
BAY 2287411 (0)
lutetium Lu 177 dotatate (2)
177Lu-LNC1010 (0)
EBTATE (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
Re (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
SSTR Expression
Neuroendocrine Tumor
SSTR Expression
Neuroendocrine Tumor
ORM-2110
Sensitive: C3 – Early Trials
ORM-2110
Sensitive
:
C3
ORM-2110
Sensitive: C3 – Early Trials
ORM-2110
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.